Alkermes News, Alkermes Quote, ALKS Quote

Alkermes (NQ:ALKS) Delayed: 52.85 --0 (-0%)

Prev. Close

$52.85

Today 6M 1Y 5Y

Open

$52.85

52 Wk High

$80.71

52 Wk Low

$27.14

Day High

$52.85

Day Low

$52.85

P/E

406.54

EPS

$0.13

Volume

Friends, Peers and Foes (?): AVDL, CNTA, BHVN, AMGN, AXSM (more...)

ALERTS | RSS

Jul 20, 2026 05:14 AM Alkermes (ALKS) PT Raised to $63 at Stifel
Jul 14, 2026 04:00 PM Alkermes to Report Second Quarter Financial Results on July 28, 2026
Jul 13, 2026 09:20 AM Alkermes (ALKS) PT Raised to $57 at TD Cowen
Jul 13, 2026 07:01 AM Alkermes drug shows sustained narcolepsy benefits at nine months
Jul 13, 2026 07:00 AM Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
Jul 13, 2026 03:13 AM JPMorgan Resumes Alkermes (ALKS) at Neutral
Jul 8, 2026 08:10 AM Alkermes terminates authorized generic supply deal with Amneal
Jul 8, 2026 08:00 AM Form 8-K Alkermes plc. For: Jul 06
Jul 6, 2026 04:48 PM Form 4 Alkermes plc. For: Jul 06 Filed by: Gaffin David Joseph
Jul 6, 2026 04:18 PM Form 144 Alkermes plc. Filed by: Gaffin David Joseph

Entities mentioned with ALKS

View All Entities